Leyland SA
The score of Leyland shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +18 % Total assets -11 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Leyland's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jul 2026
- Year ended 31 Dec 2024filed on 18 Jul 2025
- Year ended 31 Dec 2023filed on 23 Aug 2024
- Year ended 31 Dec 2022filed on 15 Jun 2023
- Year ended 31 Dec 2021filed on 22 Aug 2022
Leyland's financial analysis
- Solvency82.3%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Leyland
Leyland's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0894.530.337
- VAT number
- BE0894530337
- Peppol
- Registered · 0208:0894530337 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 28 Dec 2007
- Registered office
- 9031 Ghent
- Latest accounts
- 2025 · filed on 08 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Leyland (SA) has been based in Ghent since 2007, active in: activities of holding companies. For 2025, it reports a net profit of 85 € and equity of €1.61m; its revenue is not published. Its solvency stands at 82.3%, above the median of its sector (55.6%).
Companies similar to Leyland
Companies in the same business, of comparable size and area, outside its group.
- AWM Pharma Activities of holding companies Brussels · balance sheet €1.42m
- Pharmaquest Activities of holding companies Putte · balance sheet €1.48m
- Pharmacura Activities of holding companies Ternat · balance sheet €2.30m
- Mara-SPL Activities of holding companies Beersel · balance sheet €1.20m
- Trap Services Activities of holding companies Dilbeek · balance sheet 977,563 €
- LBJ Holding Activities of holding companies Kasterlee · balance sheet €1.02m
- PiotFarma Retail sale of pharmaceutical products Tielt-Winge · balance sheet €1.79m
- Management R.O.S.A. Retail sale of pharmaceutical products Lasne · balance sheet €3.09m
Frequently asked questions about Leyland
What is the revenue of Leyland?
Leyland files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Leyland?
In Belgium, the VAT number is the company number prefixed with BE: BE0894530337 for Leyland, if the company is VAT-registered. Its company number (CBE) is 0894.530.337.
Where is the registered office of Leyland?
According to the CBE register, the registered office of Leyland is in 9031 Ghent.
What is the equity of Leyland?
At the close of the 2025 financial year, the equity of Leyland amounts to 1,608,123 €, a solvency of 82.3% of total assets.
Who manages Leyland?
The register lists 3 active mandates at Leyland. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Leyland
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →